The price of Clover Health Investments Corp (NASDAQ:CLOV) shares last traded on Wall Street fell -2.44% to $0.90.
Based on available information, 3 analysts follow Clover Health Investments Corp (NASDAQ:CLOV). The consensus rating among analysts is ‘Overweight’. CLOV stock price is now -17.49% away from the 50-day moving average and -13.62% away from the 200-day moving average. The market capitalization of the company currently stands at $437.30M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
Among analysts, 2 rate the stock a hold while 1 rate it a buy.
With the price target reduced from $7 to $3, Cowen Upgraded its rating from Underperform to Market Perform for Clover Health Investments Corp (NASDAQ: CLOV).
In other news, Loengard Anna U, Director bought 11,000 shares of the company’s stock on Sep 06. The stock was bought for $14,300 at an average price of $1.30. Upon completion of the transaction, the Director now directly owns 10,000 shares in the company, valued at $9000.0. Insiders disposed of 1,675,895 shares of company stock worth roughly $1.51 million over the past 1 year. A total of 24.04% of the company’s stock is owned by insiders.
A candlestick chart of Clover Health Investments Corp (NASDAQ: CLOV) showed a price of $0.9200 on Wednesday morning. During the past 12 months, Clover Health Investments Corp has had a low of $0.71 and a high of $1.63. The fifty day moving average price for CLOV is $1.0931 and a two-hundred day moving average price translates $1.0441 for the stock.
The latest earnings results from Clover Health Investments Corp (NASDAQ: CLOV) was released for Sep, 2023. According to the Healthcare Plans Company, earnings per share came in at -$0.06, beating analysts’ expectations of -$0.15 by 0.09. This compares to -$0.16 EPS in the same period last year. The net profit margin was -9.33% and return on equity was -68.85% for CLOV. The company reported revenue of $482.07 million for the quarter, compared to $856.82 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -43.74 percent. For the current quarter, analysts expect CLOV to generate $494.6M in revenue.
Clover Health Investments Corp(CLOV) Company Profile
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. The company was incorporated in 2014 and is based in Franklin, Tennessee.
